Apply for Funded Services in Nanopharmaceutical Innovation!
PHOENIX-OITB has launched the 2nd Round of its Open Call. First-stage applications are due 3 May 2024. Find out more about the funded services we offer!
Read more
Why a Single Entry Point for Nanopharmaceutical Innovation?
To introduce this new enterprise to potential customers, we sat down with PHOENIX-OITB gGmbH CEO Dr. Nazende Günday-Türeli to discuss the most frequently asked questions.
PHOENIX establishes gGmbH as one-stop-shop for nanopharmaceutical development
PHOENIX-OITB gGmbH offers an “all-in-one” Single Entry Point to users, providing manufacturing, characterization, testing and innovation-related consulting services including regulatory and business guidance to accelerate maturity of nano-pharmaceuticals and diagnostic agents.